Cue Biopharma, Inc. ( NASDAQ:CUE – Get Rating ) saw a significant drop in short interest in the month of February. As of February 15th, there was short interest totalling 438,000 shares, a drop of 12.7% from the January 31st total of 501,900 shares. Based on an average daily volume of 112,400 shares, the short-interest ratio is currently 3.9 days. Analyst Ratings Changes Separately, Piper Sandler began coverage on Cue Biopharma in a research report on Sunday, November 20th. They issued an 'overweight' rating and a $7.

https://www.dailypolitical.com/2023/03/06/cue-biopharma-inc-nasdaqcue-short-interest-update.html

#dailypolitical